Building biomolecular intelligence
to cure all diseases.
构建生物分子智能，
治愈所有疾病。
A future where medicines we need are within our power to create. 让所需之药，皆可创造
Molence Bio is an AI-native biotech built on our own biomolecular foundation models. 觅深知源是一家 AI 原生的生物技术公司，以自研的生物分子基础模型为核心能力。
Our biologists, chemists, and AI researchers work side by side to advance these models and apply them to drug discovery: unlocking targets long considered undruggable, designing better molecules, and building a pipeline of therapies for unmet medical needs. 在这里，生物学家、化学家与 AI 研究者紧密协作，持续迭代基础模型，并将其应用于药物研发：攻克长期被视为“不可成药”的靶点，设计更优的分子，并推进自有管线，以满足尚未被满足的临床需求。
Mol-1
An open frontier biomolecular foundation model for drug discovery. 服务药物发现的前沿开源生物分子基础模型
We combine biomolecular structure prediction with generative design, test our predictions and designs experimentally, and use the results to continually improve our models. We publish our findings and release the weights of our core model so others can build on our work—because we believe openness helps the entire field move faster. 我们将生物分子结构预测与生成式设计相结合，用实验检验模型的预测与设计，再以实验反馈持续改进模型。我们发布研究成果，开源核心模型，让更多研究者能够在此基础上继续探索——因为我们相信，开放能让整个领域走得更快。
- 01
A foundation to build on基础模型
Biomolecular structure prediction across molecular modalities.跨分子模态的生物分子结构预测
- 02
Scaling biomolecular intelligence智能体
Scaling structure prediction to large biomolecular assemblies with long-running agents.以长程智能体，拓展生物分子结构预测的规模与边界
- 03
Design meets experiment实验验证
De novo antibody design across diverse targets, validated in the lab.面向多样化靶点的抗体从头设计与湿实验验证
